We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$984M
AUM Growth
+$75.1M
Cap. Flow
+$13.9M
Cap. Flow %
1.41%
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
2.6 years

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$11.9M
2
AMGN icon
Amgen
AMGN
+$2.76M
3
GILD icon
Gilead Sciences
GILD
+$2.63M
4
BIIB icon
Biogen
BIIB
+$1.96M
5
CELG
Celgene Corp
CELG
+$1.61M

Sector Composition

Rank Sector Weight
1 Financials 35.78%
2 Healthcare 22.38%
3 Industrials 11.22%
4 Technology 7.01%
5 Consumer Staples 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NOV icon
26
NOV
NOV
$6.64B
$9.7M 0.99%
225,100
– –
2014 Q1
18 quarters
BBL
27
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$9.26M 0.94%
210,530
– –
2017 Q4
3 quarters
CL icon
28
Colgate-Palmolive
CL
$73.9B
$9.01M 0.92%
134,590
+18,890
+16% +$1.26M
2018 Q2
1 quarter
BUD icon
29
AB InBev
BUD
$160B
$8.49M 0.86%
96,950
+27,950
+41% +$2.72M
2015 Q3
12 quarters
CSCO icon
30
Cisco
CSCO
$433B
$7.69M 0.78%
158,000
– –
2014 Q1
18 quarters
AMGN icon
31
Amgen
AMGN
$235B
$7.08M 0.72%
34,130
-14,000
-29% -$2.76M
2015 Q4
11 quarters
VOO icon
32
Vanguard S&P 500 ETF
VOO
$1.05T
$6.86M 0.7%
25,690
– –
2017 Q2
5 quarters
GILD icon
33
Gilead Sciences
GILD
$195B
$6.54M 0.66%
84,650
-34,800
-29% -$2.63M
2014 Q4
15 quarters
SNY icon
34
Sanofi
SNY
$96.5B
$6.12M 0.62%
137,040
– –
2014 Q1
18 quarters
USB icon
35
US Bancorp
USB
$89.4B
$6.06M 0.62%
114,700
+1,800
+2% +$95.4K
2016 Q2
9 quarters
BDX icon
36
Becton Dickinson
BDX
$52.8B
$5.95M 0.61%
23,370
– –
2014 Q1
18 quarters
GE icon
37
GE Aerospace
GE
$324B
$5.89M 0.6%
108,838
+3,192
+3% +$197K
2017 Q4
3 quarters
VDC icon
38
Vanguard Consumer Staples ETF
VDC
$7.93B
$5.69M 0.58%
40,600
+14,180
+54% +$1.98M
2018 Q2
1 quarter
BIIB icon
39
Biogen
BIIB
$34.8B
$5.04M 0.51%
14,260
-5,680
-28% -$1.96M
2015 Q4
11 quarters
MDT icon
40
Medtronic
MDT
$122B
$4.99M 0.51%
50,700
– –
2014 Q1
18 quarters
RDS.B
41
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$4.75M 0.48%
67,000
– –
2018 Q2
1 quarter
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.22T
$4.66M 0.47%
78,000
– –
2014 Q1
18 quarters
SGYP
43
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$4.25M 0.43%
2,500,000
+200,000
+9% +$358K
2017 Q1
6 quarters
CELG
44
DELISTED
Celgene Corp
CELG
$4.13M 0.42%
46,170
-18,200
-28% -$1.61M
2015 Q4
11 quarters
BMY icon
45
Bristol-Myers Squibb
BMY
$124B
$3.85M 0.39%
62,080
– –
2016 Q2
9 quarters
IBB icon
46
iShares Biotechnology ETF
IBB
$10.6B
$3.16M 0.32%
25,900
– –
2018 Q1
2 quarters
MO icon
47
Altria Group
MO
$123B
$2.92M 0.3%
48,450
+15,950
+49% +$947K
2018 Q1
2 quarters
SRCL icon
48
DELISTED
Stericycle Inc
SRCL
$2.79M 0.28%
47,600
– –
2015 Q1
14 quarters
AKTX icon
49
Akari Therapeutics
AKTX
$20.2M
$2.56M 0.26%
1,250
+195
+18% +$315K
2017 Q2
5 quarters
ASHR icon
50
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
$2.45M 0.25%
96,500
+35,800
+59% +$899K
2017 Q2
5 quarters

Similar funds

Hikari Power's Q3 2018 Portfolio in Review

As of Q3 2018, Hikari Power held 135 positions worth $984M, up 8.3% from $908M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hikari Power's Q3 2018 filing shows 7 new, 20 increased, 9 reduced and 8 closed positions. Its largest new stake was Bank of New York Mellon: 25,300 shares worth $1.29M. The largest sale was IBM, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2018 buy was Bank of New York Mellon: 25,300 shares worth $1.29M.
  • Hikari Power added most to Allergan plc in Q3 2018, an estimated $6.77M increase.
  • Hikari Power's biggest Q3 2018 reduction was IBM, cutting an estimated $11.9M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2018, selling an estimated $916K.
  • Hikari Power's ten largest holdings make up 55% of its $984M portfolio in Q3 2018.
  • Hikari Power opened 7 new positions and closed 8 in Q3 2018.
  • Hikari Power's portfolio value rose 8.3% quarter-over-quarter to $984M.

Based on Hikari Power's 13F filing for Q3 2018, filed 31 Oct 2018.